Another YAP-transcriptional suppressor, Vestigial-like-4 (VGLL-4), has also recently emerged as a novel tumour suppressor in colon cancer by regulating both the YAP/TAZ and β-catenin-TCF4 complex [30]. Here, YAP1 is linked to malignant colon neoplasm.